Hainan Drinda New Energy Technology (002865) H1 2025 earnings summary

Executive summary

• H1 revenue fell 42.5% YoY to RMB3.656bn as mainland sales weakened; overseas sales rose to 52.0% of revenue, while the period loss widened to RMB263.7m.

• Operating focus remained N-type cell efficiency and cost improvements, overseas market expansion and development of overseas capacity.

Financial highlights

• Revenue was RMB3,655.6m, down 42.5% YoY; sales cost fell 42.7% to RMB3,654.6m as cell sales volume and silicon-wafer prices declined.

• Gross profit was RMB0.9m versus a gross loss of RMB23.8m in H1 2024, supported by production optimization and higher-margin overseas sales.

• Net loss widened to RMB263.7m from RMB166.3m; pretax loss was RMB315.6m versus RMB242.2m, with finance costs up 19.6% to RMB127.4m.

• Net operating cash inflow was RMB1,031.9m versus RMB130.4m; cash and equivalents ended June at RMB3,253.1m, up from RMB2,616.3m at year-end.

Outlook and guidance

• Plans prioritize continued N-type technology upgrades, cost reduction, overseas customer development and execution of overseas capacity projects; no numerical earnings guidance was stated.

• The 5GW Oman cell-base plan will be advanced cautiously after assessing trade, tariff, market and project-return risks.

• Management expects industry supply-demand conditions and prices to improve as capacity exits and policy measures promote orderly competition; it anticipates an opportunity for earnings recovery.